---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-253858"
form_type: "8-K"
ticker: "BTMD"
cik: "0001819253"
company_name: "biote Corp."
filed_at: "2026-06-02T21:17:02+00:00"
generated_at: "2026-06-02T21:18:29.116542+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biote CEO Christensen resigns; CFO Peterson named Interim CEO; Marc Beer Executive Chairman; FY2026 guidance reaffirmed

## Summary
- Bret Christensen resigns as CEO effective June 8, 2026 for personal/family reasons; remains a Class III director.
- CFO and Chief Business Officer Bob Peterson appointed Interim CEO and director; search for permanent CFO initiated.
- Chairman Marc Beer becomes Executive Chairman with base salary of $521,200, bonus up to 85%, and option for 114,157 shares.
- Company reaffirms FY2026 guidance: revenue above $190M, Adjusted EBITDA above $38M; expects procedure revenue growth in H2.
- Separation agreement for Christensen includes 3-month option exercise period and 130,000-share stock option grant.

## SEC filing metadata
- accession: 0001193125-26-253858
- form_type: 8-K
- ticker: BTMD
- cik: 0001819253
- company_name: biote Corp.
- filed_at: 2026-06-02T21:17:02+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819253/000119312526253858/0001193125-26-253858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819253/000119312526253858/d215108d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-253858
- JSON: https://secwatch.observer/filing/0001193125-26-253858.json
- Plain text: https://secwatch.observer/filing/0001193125-26-253858.txt

## Source-grounded claims
- claim_id: 0058955ef4
  claim: Marc Beer was appointed as Executive Chairman of the Board at biote Corp..
  evidence_excerpt: On June 1, 2026, the Board appointed Marc Beer as Executive Chairman of the Board, effective June 8, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312526253858/0001193125-26-253858-index.htm
- claim_id: 27db87c687
  claim: Bret Christensen resigned as Chief Executive Officer at biote Corp..
  evidence_excerpt: On May 27, 2026, the Board of Directors (the “Board”) of biote Corp. (the “Company”) accepted the resignation of Bret Christensen, the Company’s Chief Executive Officer, from his position as Chief Executive Officer of BioTE Medical, LLC (“BioTE”), effective as of June 8, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312526253858/0001193125-26-253858-index.htm
- claim_id: c7de1b8a30
  claim: Robert Peterson was appointed as Interim Chief Executive Officer at biote Corp..
  evidence_excerpt: Concurrently, the Board appointed Robert Peterson, current Chief Financial Officer and Chief Business Officer of BioTE, as Interim Chief Executive Officer of BioTE to fill the vacancy created by Mr. Christensen’s resignation, and as a director of the Board, each effective June 8, 2026 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312526253858/0001193125-26-253858-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.